, 172 , 3929-3943, doi: Zheng, W., Zhou, C
Inhibition of renal prostaglandin synthesis can lead to a variety of detrimental effects if kidney function is less than optimal, including fluid and electrolyte disorders, acute renal dysfunction, nephrotic syndrome, interstitial nephritis, and renal papillary necrosis
This article focuses on the basic mechanisms and actions of selected gut hormones/dual-agonists [glucagon-like-peptide (GLP-1), glucose-dependent insulinotropic peptide (GIP), and glucagon] and summarize the outcomes of trials evaluating these incretin agonists [2]

Nooms GLP-1 companion delivers the following features: Educational resources tailored to GLP-1s, the importance of healthy habits alongside the med, and side-effect management A Med Tracker with reminders, a medication log, and integrated side-effect support to deliver persistence and greater weight loss outcomes Protein-focused nutrition support with photo meal logging to preserve lean mass Muscle Defense exercise plan that includes personalized movement goals and accessible resistance training workouts to preserve lean mass A PDURS-like solution that addresses the label indication: to be used in combination with a reduced-calorie diet and increased physical activity The same powerful behavior change engine that supports our Noom GLP-1 Rx product has been built to support any weight loss medication, noted Cook

Low-dose naltrexone (LDN) has emerged as one of the most promising agents in this area, working through glial cell modulation to reduce neuroinflammation and through toll-like receptor pathways to quiet abnormal immune activation
Cefepime and diclofenac sodium combined treatment-potentiated multiple organ injury: role of oxidative damage and disrupted lipid metabolism